Back to Search
Start Over
Findings on Multiple Myeloma Detailed by Investigators at Bristol-Myers Squibb Company (Pharmacodynamic Changes In Tumor and Immune Cells Drive Iberdomide's Clinical Mechanisms of Activity In Relapsed and Refractory Multiple Myeloma)
Findings on Multiple Myeloma Detailed by Investigators at Bristol-Myers Squibb Company (Pharmacodynamic Changes In Tumor and Immune Cells Drive Iberdomide's Clinical Mechanisms of Activity In Relapsed and Refractory Multiple Myeloma)
- Source :
- Hematology Week. July 29, 2024, 113
- Publication Year :
- 2024
-
Abstract
- 2024 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- A new study on Oncology - Multiple Myeloma is now available. According to news reporting [...]
Details
- Language :
- English
- ISSN :
- 1543673X
- Database :
- Gale General OneFile
- Journal :
- Hematology Week
- Publication Type :
- News
- Accession number :
- edsgcl.802832550